ADDEX THERAP. SF 0,01/ CH0029850754 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -EUR | - | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 13.02 mill.EUR | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.14 CHF | -69.57% |
| EPS Diluted: | - CHF | -69.57% |
| Revenues per Share: | 0.01 CHF | -23.86% |
| Book Value per Share: | 0.01 CHF | -84.90% |
| Cash Flow per Share: | -0.04 CHF | -68.52% |
| Dividend per Share: | - CHF | - |
| Total | in mill. | |
| Revenues: | 1.65 CHF | 17.65% |
| Net Income: | -10.56 CHF | -49.25% |
| Operating Cash Flow: | -7.99 CHF | - |
| Cash and Cash Equivalents: | 3.87 CHF | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 7.75 | 4.98 |
| P/BV ratio: | 11.14 | 7.16 |
| P/CF Ratio: | -1.60 | -1.03 |
| PEG: | 0.01 | - |
| Earnings Yield: | -195.53% | -304.35% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 13.02 mill. EUR | 8.83 mill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 178.23 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | -624.22% |
| Net Profit Margin: | -640.91% |
| Return on Equity: | -921.57% |
| Return on Assets: | -227.41% |
Financial Strength
| Liquidity I / Cash Ratio: | 133.60% |
| Liquidity II / Quick Ratio: | 137.42% |
| Liquidity III / Current Ratio: | 146.37% |
| Debt / Equity Ratio: | 305.25% |
| Dynam. Debt / Equity Ratio: | -43.75% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - CHF |
| Revenues / Employee: | - CHF |
| Net Income / Employee: | - CHF |
| Total Assets / Employee: | - CHF |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | CHF |
